Neogenomics Inc (NASDAQ:NEO)

8.16
Delayed Data
As of Jun 30
 -0.17 / -2.04%
Today’s Change
6.85
Today|||52-Week Range
54.74
-76.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues99.8M244.1M258.6M276.7M
 
 
 
 
 
Cost of Goods Sold51.8M114.9M122.0M141.3M
 
 
 
 
 
Depreciation And Amortization7.1M23.2M22.6M21.7M
 
 
 
 
 
 
Operating ExpensesGross Income40.9M106.0M114.0M113.7M
 
 
 
 
 
General Expenses41.8M99.9M110.6M101.4M
 
 
 
 
 
Research And Development4.0M4.4M3.5M3.0M
 
 
 
 
 
Total Operating Expenses100.7M238.0M255.2M264.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-935.0K6.0M3.4M12.3M
 
 
 
 
 
Extraordinary Charge-4.7M-3.5M0.00-2.3M
 
 
 
 
Interest Expense On Debt854.0K10.0M5.5M6.2M
 
 
 
 
 
Other Expenses2.0M0.00-1.3M14.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-7.4M-3.5M3.8M
 
 
 
 
 
Income Taxes-2.0M-1.7M-2.6M-1.2M
 
 
 
 
 
Preferred Dividend-122.0K-24.7M-10.5M-3.4M
 
 
 
 
 
Net Income-2.5M-5.7M-846.0K2.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.5M77.5M79.4M85.6M
 
 
 
 
 
Shares To Calculate EPS Diluted60.5M77.5M79.4M91.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.39-$0.14$0.07
 
 
 
 
 
EPS Diluted-$0.04-$0.39-$0.14$0.07